- Home
- INAB vs EKSO Comparison
INAB vs EKSO Comparison
Compare INAB & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INAB
- EKSO
- Stock Information
- Founded
- INAB 2016
- EKSO 2005
- Country
- INAB United States
- EKSO United States
- Employees
- INAB N/A
- EKSO N/A
- Industry
- INAB Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- INAB Health Care
- EKSO Health Care
- Exchange
- INAB Nasdaq
- EKSO Nasdaq
- Market Cap
- INAB 14.5M
- EKSO 11.7M
- IPO Year
- INAB 2021
- EKSO N/A
- Fundamental
- Price
- INAB $2.49
- EKSO $3.57
- Analyst Decision
- INAB Strong Buy
- EKSO Strong Buy
- Analyst Count
- INAB 2
- EKSO 2
- Target Price
- INAB $108.00
- EKSO $37.50
- AVG Volume (30 Days)
- INAB 185.2K
- EKSO 259.7K
- Earning Date
- INAB 08-07-2025
- EKSO 07-28-2025
- Dividend Yield
- INAB N/A
- EKSO N/A
- EPS Growth
- INAB N/A
- EKSO N/A
- EPS
- INAB N/A
- EKSO N/A
- Revenue
- INAB N/A
- EKSO $17,544,000.00
- Revenue This Year
- INAB N/A
- EKSO $0.20
- Revenue Next Year
- INAB N/A
- EKSO $42.29
- P/E Ratio
- INAB N/A
- EKSO N/A
- Revenue Growth
- INAB N/A
- EKSO N/A
- 52 Week Low
- INAB $2.05
- EKSO $2.73
- 52 Week High
- INAB $27.30
- EKSO $22.95
- Technical
- Relative Strength Index (RSI)
- INAB 44.14
- EKSO 44.68
- Support Level
- INAB $2.10
- EKSO $3.14
- Resistance Level
- INAB $2.30
- EKSO $3.57
- Average True Range (ATR)
- INAB 0.13
- EKSO 0.38
- MACD
- INAB 0.10
- EKSO 0.10
- Stochastic Oscillator
- INAB 96.70
- EKSO 64.62
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.